DK1107986T3 - Proteindomæner i den hæpatiske glycogenmålretnings-subunit af proteinphosphatase 1 og fremgangsmåder til fremstilling og anvendelse deraf - Google Patents

Proteindomæner i den hæpatiske glycogenmålretnings-subunit af proteinphosphatase 1 og fremgangsmåder til fremstilling og anvendelse deraf

Info

Publication number
DK1107986T3
DK1107986T3 DK99940382T DK99940382T DK1107986T3 DK 1107986 T3 DK1107986 T3 DK 1107986T3 DK 99940382 T DK99940382 T DK 99940382T DK 99940382 T DK99940382 T DK 99940382T DK 1107986 T3 DK1107986 T3 DK 1107986T3
Authority
DK
Denmark
Prior art keywords
protein
methods
preparing
hepatic glycogen
targeting subunit
Prior art date
Application number
DK99940382T
Other languages
English (en)
Inventor
Patricia Townsend Wade Cohen
Christopher George Armstrong
Martin John Doherty
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of DK1107986T3 publication Critical patent/DK1107986T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK99940382T 1998-08-27 1999-08-19 Proteindomæner i den hæpatiske glycogenmålretnings-subunit af proteinphosphatase 1 og fremgangsmåder til fremstilling og anvendelse deraf DK1107986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818650.5A GB9818650D0 (en) 1998-08-27 1998-08-27 Therapeutic compounds and methods of making and using the same
PCT/GB1999/002761 WO2000012549A1 (en) 1998-08-27 1999-08-19 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same

Publications (1)

Publication Number Publication Date
DK1107986T3 true DK1107986T3 (da) 2007-09-24

Family

ID=10837894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940382T DK1107986T3 (da) 1998-08-27 1999-08-19 Proteindomæner i den hæpatiske glycogenmålretnings-subunit af proteinphosphatase 1 og fremgangsmåder til fremstilling og anvendelse deraf

Country Status (11)

Country Link
US (1) US6710026B1 (da)
EP (1) EP1107986B1 (da)
JP (1) JP2002532381A (da)
AT (1) ATE365747T1 (da)
AU (1) AU768265B2 (da)
CA (1) CA2340885A1 (da)
DE (1) DE69936388T2 (da)
DK (1) DK1107986T3 (da)
ES (1) ES2289820T3 (da)
GB (1) GB9818650D0 (da)
WO (1) WO2000012549A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2254347C2 (ru) * 2000-03-17 2005-06-20 Дау Глобал Текнолоджиз Инк. Полиолефиновый пенопласт, используемый для звуко- и теплоизоляции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416871A (en) * 1978-07-10 1983-11-22 The United States Of America As Represented By The Department Of Health And Human Services Inhibition by peptides of tolerance to and physical dependence on morphine
ATE398287T1 (de) 1996-03-30 2008-07-15 Medical Res Council Wechselwirkungen der katalytischen untereinheit der proteinphosphatase 1
US5939284A (en) * 1996-12-05 1999-08-17 Smithkline Beecham Corporation Protein phosphatase 1 binding protein, R5

Also Published As

Publication number Publication date
AU768265B2 (en) 2003-12-04
CA2340885A1 (en) 2000-03-09
EP1107986B1 (en) 2007-06-27
ES2289820T3 (es) 2008-02-01
GB9818650D0 (en) 1998-10-21
EP1107986A1 (en) 2001-06-20
DE69936388T2 (de) 2008-02-28
US6710026B1 (en) 2004-03-23
AU5436899A (en) 2000-03-21
WO2000012549A1 (en) 2000-03-09
ATE365747T1 (de) 2007-07-15
JP2002532381A (ja) 2002-10-02
DE69936388D1 (de) 2007-08-09

Similar Documents

Publication Publication Date Title
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
EA200001176A1 (ru) Гетероциклические ингибиторы p38
BR9913532A (pt) Novos inibidores heteroaromáticos de frutose 1,6-bifosfatase
DE60037578D1 (de) Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
DE69530763D1 (de) Antikörper gegen e-selektin
EA200100589A1 (ru) Азабициклоалканы как модуляторы ccr5
NO20010446L (no) Substituert anilidforbindelser og metoder
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE59810761D1 (de) Verwendung von vasopressin-antagonisten zur behandlung von störungen oder erkrankungen des innenohres
FI972703A0 (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
BR0116357A (pt) Concentrados de sabor
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE213233T1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
DK1107986T3 (da) Proteindomæner i den hæpatiske glycogenmålretnings-subunit af proteinphosphatase 1 og fremgangsmåder til fremstilling og anvendelse deraf
TR200200278T2 (tr) Kalsilitik bileşimler
BR9814188A (pt) "agonistas de 5-ht1f"
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DE69929683D1 (de) Antisense modulierung von lfa-3
DE69934580D1 (de) Mit cd40 und traf interagierende proteine
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen